A case of immunoglobulin 4-related disease with bilateral mass-forming lesions in the nasolacrimal ducts

Journal of Clinical Rheumatology

Volumn 17, Issue 4, 2011, Pages 207-210

  Suzuki, Masanobu ^a   Mizumachi, Takatsugu ^b   Morita, Shinya ^a   Kubota, Kanako ^c   Iizuka, Keiji ^a  

^a Kushiro City General Hospital   (Japan)

^b Department of Otolaryngology Head and Neck Surgery ^*  (United States)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

IgG4 related disease; Mikulicz disease; Nasal tumor; Primary acquired nasolacrimal duct obstruction (PANDO)

Indexed keywords

IMMUNOGLOBULIN G4; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DYSGAMMAGLOBULINEMIA; EPIPHORA; EYE DISEASE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LACRIMAL DUCT; MALE; NASOLACRIMAL DUCT TUMOR; PLASMA CELL; PRIORITY JOURNAL; SYMPTOM; TUMOR;

AUTOIMMUNE DISEASES; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MIKULICZ' DISEASE; NASOLACRIMAL DUCT; PLASMA CELLS; PREDNISOLONE; TREATMENT OUTCOME;

EID: 80051781518     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31821c71a3     Document Type: Article

References (9)

1. Morgan WS, Castleman B. A cliniopathologic study of Mikulicz's disease. Am J Pathol. 1953;29:471-503.
2. Yamamoto M, Harada S, Ohara M, et al. Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome. Rheumatology. 2005;44:227-234. (Pubitemid 40277409)
3. Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68: 1310-1315.
4. Brouwer E, Tervaert JW, Horst G, et al. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol. 1991;83:379-386.
5. Matsubayashi H, Furukawa H, Maeda A, et al. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Pancreatology. 2009;9:694-699.
6. Shigekawa M, Yamao K, Sawaki A, et al. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis? J Hepatobiliary Pancreat Surg. 2009;17:269-274.
7. Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood. 2007;110:3507-3516. (Pubitemid 350159614)
8. Levin A, Kasem S, Mader R, et al. Wegener granulomatosis with back pain, periaortitis, and dural inflammation developing while receiving monthly cyclophosphamide. J Clin Rheumatol. 2006;12:294-297. (Pubitemid 44915329)
9. Lee-Wing MW, Ashenhurst ME. Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction. Ophthalmology. 2001;108:2038-2040.